Oryzon Genomics a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating iadadems...
The HMarBCN -CNIO Cancer Immunotherapy Clinical Research Unit has just received funding from the Deutsche José Carreras Leukämie Stiftung for a project aimed at modifying T cells directly within the...
The study has identified SIRT7, a protein involved in how cells respond to stress and ageing, and how it plays a critical role in maintaining the health of the X chromosome.
Research by the Barcelona Institute for Biomedical Research (IIBB), part of the Spanish National Research Council (CSIC), and the Institut de Recerca Sant Pau (IR Sant Pau) provides some of the first ...
La investigación, publicada en la revista Open Forum Infectious Diseases, analizó 261 episodios de bacteriemia por Campylobacter registrados entre 2009 y 2024 en 27 hospitales de España, Reino Unid...